STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $23.74 billion. The enterprise value is $25.77 billion.
| Market Cap | 23.74B |
| Enterprise Value | 25.77B |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | Jun 10, 2025 |
Share Statistics
STERIS has 98.37 million shares outstanding. The number of shares has decreased by -0.29% in one year.
| Current Share Class | 98.37M |
| Shares Outstanding | 98.37M |
| Shares Change (YoY) | -0.29% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 96.57% |
| Float | 97.99M |
Valuation Ratios
The trailing PE ratio is 39.18 and the forward PE ratio is 24.02.
| PE Ratio | 39.18 |
| Forward PE | 24.02 |
| PS Ratio | 4.36 |
| Forward PS | 4.05 |
| PB Ratio | 3.59 |
| P/TBV Ratio | 36.34 |
| P/FCF Ratio | 30.52 |
| P/OCF Ratio | 20.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.60, with an EV/FCF ratio of 33.13.
| EV / Earnings | 41.93 |
| EV / Sales | 4.72 |
| EV / EBITDA | 17.60 |
| EV / EBIT | 26.08 |
| EV / FCF | 33.13 |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.96 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | 2.83 |
| Interest Coverage | 11.46 |
Financial Efficiency
Return on equity (ROE) is 9.46% and return on invested capital (ROIC) is 6.67%.
| Return on Equity (ROE) | 9.46% |
| Return on Assets (ROA) | 5.82% |
| Return on Invested Capital (ROIC) | 6.67% |
| Return on Capital Employed (ROCE) | 10.83% |
| Revenue Per Employee | $306,938 |
| Profits Per Employee | $34,556 |
| Employee Count | 17,787 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 4.84 |
Taxes
In the past 12 months, STERIS has paid $184.65 million in taxes.
| Income Tax | 184.65M |
| Effective Tax Rate | 23.19% |
Stock Price Statistics
The stock price has increased by +6.86% in the last 52 weeks. The beta is 0.94, so STERIS's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | +6.86% |
| 50-Day Moving Average | 231.96 |
| 200-Day Moving Average | 225.31 |
| Relative Strength Index (RSI) | 53.17 |
| Average Volume (20 Days) | 623,849 |
Short Selling Information
The latest short interest is 899,743, so 0.91% of the outstanding shares have been sold short.
| Short Interest | 899,743 |
| Short Previous Month | 1.34M |
| Short % of Shares Out | 0.91% |
| Short % of Float | 0.92% |
| Short Ratio (days to cover) | 1.14 |
Income Statement
In the last 12 months, STERIS had revenue of $5.46 billion and earned $614.64 million in profits. Earnings per share was $6.21.
| Revenue | 5.46B |
| Gross Profit | 2.42B |
| Operating Income | 988.23M |
| Pretax Income | 550.80M |
| Net Income | 614.64M |
| EBITDA | 1.46B |
| EBIT | 988.23M |
| Earnings Per Share (EPS) | $6.21 |
Balance Sheet
The company has $171.70 million in cash and $2.20 billion in debt, giving a net cash position of -$2.03 billion or -$20.64 per share.
| Cash & Cash Equivalents | 171.70M |
| Total Debt | 2.20B |
| Net Cash | -2.03B |
| Net Cash Per Share | -$20.64 |
| Equity (Book Value) | 6.62B |
| Book Value Per Share | 67.18 |
| Working Capital | 978.59M |
Cash Flow
In the last 12 months, operating cash flow was $1.15 billion and capital expenditures -$370.09 million, giving a free cash flow of $778.00 million.
| Operating Cash Flow | 1.15B |
| Capital Expenditures | -370.09M |
| Free Cash Flow | 778.00M |
| FCF Per Share | $7.91 |
Margins
Gross margin is 44.31%, with operating and profit margins of 18.10% and 11.26%.
| Gross Margin | 44.31% |
| Operating Margin | 18.10% |
| Pretax Margin | 14.58% |
| Profit Margin | 11.26% |
| EBITDA Margin | 26.82% |
| EBIT Margin | 18.10% |
| FCF Margin | 14.25% |
Dividends & Yields
This stock pays an annual dividend of $2.28, which amounts to a dividend yield of 0.94%.
| Dividend Per Share | $2.28 |
| Dividend Yield | 0.94% |
| Dividend Growth (YoY) | 9.62% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 36.74% |
| Buyback Yield | 0.29% |
| Shareholder Yield | 1.24% |
| Earnings Yield | 2.59% |
| FCF Yield | 3.28% |
Analyst Forecast
The average price target for STERIS is $261.00, which is 8.15% higher than the current price. The consensus rating is "Buy".
| Price Target | $261.00 |
| Price Target Difference | 8.15% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 6.66% |
| EPS Growth Forecast (5Y) | 16.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
STERIS has an Altman Z-Score of 5.05 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.05 |
| Piotroski F-Score | 7 |